Health Canada inspection
CIUSSS de l'Est-de-l'Île-de-Montréal - Hôpital Maisonneuve-Rosemont - Programme de greffe et thérapie cellulaire: Health Canada inspection of Dec 8, 2025
Health Canada · rating C
Key facts
| Establishment | CIUSSS de l'Est-de-l'Île-de-Montréal - Hôpital Maisonneuve-Rosemont - Programme de greffe et thérapie cellulaire |
|---|---|
| City | Montréal |
| Province | Quebec |
| Country | Canada |
| Start date | Dec 8, 2025 |
| Rating | C |
| Rating description | Compliant |
At a glance
- 1–9 Inspections of this establishment
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.